Beta Bionics, INC Form 4 insider transactions

Director Sean Carney of Beta Bionics, Inc. acquired stock options on January 31, 2025, for 86,293 shares of common stock.

Wellington Hadley Harbor Aggregator IV, L.P. reports acquiring 1,000,000 shares of Beta Bionics common stock at $17 per share in a private placement, alongside the conversion of preferred stock into common stock.

Sean Saint, CEO of Beta Bionics, reports the acquisition of stock options exercisable for 467,944 shares of Class B Common Stock (later converted to Common Stock) on January 29, 2025.

Steven Jon Russell, Chief Medical Officer of Beta Bionics, Inc., reports the acquisition of stock options.

Mike Mensinger, Chief Product Officer of Beta Bionics, acquired stock options for 110,278 shares of Class B Common Stock on January 29, 2025.

Mark Hopman, Chief Commercial Officer of Beta Bionics, acquired 47,775 employee stock options on January 29, 2025.

Stephen Feider, CFO of Beta Bionics, reports the acquisition of stock options exercisable for 186,203 shares of common stock.